Thursday, May 02, 2024
Monteris Medical has introduced its latest advancement in image-guided laser interstitial thermal therapy (LITT) with the launch of the NeuroBlate® NB3™ FullFire® 1.6mm laser probe. This new addition to the NeuroBlate System represents a significant milestone in neurosurgical technology.
The NB3 probe, equipped with Monteris' patented cooling technology and state-of-the-art laser fiber technology, is now the smallest commercially available laser probe specifically designed for brain procedures.
Having received FDA 510(k) clearance in December 2023 and undergoing limited market release since February 2024, the NB3 probe has garnered attention in top medical institutions across the United States.
During its initial rollout, surgeons have explored its capabilities across a wide range of procedures, including the treatment of primary tumors, metastatic lesions, radiation necrosis, and epileptogenic foci, catering to both adult and pediatric patients.
A standout feature of the NB3 probe is its adaptability, allowing for use in multi-trajectory procedures while maintaining convenience for neurosurgeons during operations. Additionally, its singular design simplifies inventory management for hospitals, providing economic value.
The NB3 probe offers a range of power settings, from six to 12 watts, enabling precise ablations of various sizes. Physicians have noted shorter ablation times, highlighting the efficiency of this advanced tool.
Monteris is poised to showcase the NB3 laser probe alongside upcoming advancements in thermography for the NeuroBlate System at the American Academy of Neurological Surgeons (AANS) annual meeting in Chicago from May 3-6, 2024. Attendees can explore the capabilities of the NB3 probe firsthand at Booth 854 and further delve into its potential at the AANS "Breakfast Bites" Educational Symposium on May 4.
Monteris expressed enthusiasm about the release of the NB3 probe, emphasizing its ability to meet the evolving needs of neurosurgeons and their patients.Highlighted the platform's forward-thinking engineering, hinting at future innovations, and underscored Monteris' commitment to empowering neurosurgeon customers with expanded software options in the near term.
Source: prnewswire.com
